← Back to patent-cliff list
氯噻酮
Tier C — Watch / tradeChlorthalidone
赛诺菲
Originator
1959
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Thiazide-sensitive sodium-chloride cotransporter
Brand：Hygroton、HemiClor、Thalitone
Indications (approved)：高血压、水肿、尿崩症、肾结石
Regional status
US
批准上市
1960-04-07
EU
批准上市
1959-01-01
China
批准上市
1985-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Chlorthalidone?
Approved indications include: 高血压, 水肿, 尿崩症, 肾结石.
When does the Chlorthalidone patent expire?
No public expiry year is available for Chlorthalidone yet; this page updates once verified.
How do I get a quote for Chlorthalidone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25